Emulate Contract Research Services

A major factor contributing to the failure of approximately 90% of drug candidates during clinical trials is the notable species differences between animals and humans. Organ-Chips represent a groundbreaking approach, as they integrate human cells in a physiologically relevant microenvironment to create a more precise model of human biology. For researchers seeking to harness the advantages of Organ-on-a-Chip technology without committing internal resources toward its implementation in-house, Emulate Contract Research Services provides a convenient avenue for pharmaceutical companies to access rapid and robust insights into human response, ultimately facilitating the progression of higher-quality drug candidates to clinical trials. Find out more about these service offerings for the drug development pipeline.